Tariffs & Supplements: How Brands Can Stay Competitive in 2026

Supplement tariffs in 2026 have quietly become one of the most disruptive forces in the dietary supplement industry, and most brand owners are still reacting instead of planning.

The Trump administration's reciprocal tariffs on imported goods have sent raw material costs climbing. For supplement brands relying on offshore dietary supplement ingredients, the pressure on margins isn't going away.

But not every brand is equally exposed. The ones who understand where their supply chain is vulnerable — and where opportunity actually exists inside this tariff environment — are already repositioning. Capsule manufacturing, in particular, presents a strategic opening that most brands haven't considered yet.

This isn't a doom-and-gloom story about supplement reformulation and rising costs. It's a practical look at how smart brands are using the current tariff landscape to make leaner decisions, and how the right manufacturing partner in the United States can be the difference between shrinking margins and a stronger competitive position.

If you've been asking how supplement tariffs in 2026 will affect your business, you're asking the right question. Let's get into it.

Recap 2025-2026 U.S. Policy Changes

On April 2, 2025, the Trump administration announced sweeping reciprocal tariffs that sent the supplement industry scrambling to assess exposure. 

The immediate question for every brand owner was the same: Which of my ingredients just got more expensive? The answer depends heavily on what you make.

The White House published Annex II, a list of products exempt from both the global tariff and reciprocal tariffs. For the supplement industry, the exemptions covered a meaningful but limited set of ingredients: vitamins A, B1, B2, B5, B6, B12, C, and E, folic acid, niacin, niacinamide, CoQ10, choline, and many amino acids and minerals.

For brands built around multivitamins, foundational mineral formulas, or amino acid-based products, this was welcome relief.

But botanicals, herbal extracts, and specialty compounds — many sourced from China and India — faced some of the steepest tariff exposure with no exemption in sight.

Then everything shifted again. On February 20, 2026, the Supreme Court ruled 6-3 in Learning Resources Inc. v. Trump that IEEPA does not authorize the President to impose tariffs. 

That sounds like a clean resolution, but it wasn’t.

Within hours of the decision, President Trump announced the imposition of 10% global tariffs under Section 122 of the Trade Act of 1974. Section 122 tariffs are legally distinct from IEEPA and they carry their own timeline and uncertainty.

The challenge has not just been the size of the tariffs but the instability surrounding them. Over the past year, businesses were forced to make hiring, pricing, and investment decisions against a backdrop of rapidly shifting trade policy, with rates changing with little notice and creating serious planning challenges for firms managing inventory, contracts, and payroll.

For supplement brands, that instability is the real story.

The tariff environment is not resolved. It has simply changed shape. Brands that spent 2025 scrambling to react are now facing a new round of the same question: How exposed is my supply chain, and what can I do about it?

Here's how to frame your ingredient exposure right now:

• Relatively protected: Core vitamins, most minerals, amino acids, CoQ10, omega-3 fatty acids.

• Still at risk: Botanical extracts, herbal blends, specialty compounds, and novel ingredients sourced internationally — particularly from China.

• Finished products: The broader tariff structure around finished dietary supplements remains in flux and should not be assumed safe without verification.

Risks for Supplement Brands 

Tariffs don't create just one problem. They create a cascade of them. Here are the risks every supplement brand owner needs to understand before they show up in your P&L.

1. Rising Ingredient Costs With No Easy Offset

The most visible pressure is cost. For brands sourcing botanicals, herbal extracts, or specialty compounds internationally, tariff exposure translates directly into margin compression that is difficult to absorb and even harder to pass to consumers without risking volume. 

2. Supply Chain Bottlenecks and Extended Lead Times

Component suppliers for capsules, bottles, and packaging have implemented new pricing with no rollbacks in sight. Brands that planned 45-day lead times are now building in 90 to 120 days. The ones that didn't adjust are the ones missing launch windows.

3. Ingredient Adulteration Risk

When an ingredient facing a 50% tariff creates significant cost pressure, some suppliers look for ways to reduce that cost — and the easiest way is adulteration. In a high-tariff environment, brands relying solely on supplier Certificates of Analysis without independent testing are the most exposed.

4. Reformulation Driven by Price, Not Efficacy

When costs climb, brands face a quiet but damaging temptation to reformulate down. Swapping premium ingredients for cheaper alternatives is a short-term fix with long-term brand consequences. Consumers notice when products stop working. That trust, once lost, is expensive to rebuild.

5. Compliance Exposure From Rushed Sourcing Decisions

When brands scramble to find alternative suppliers quickly, compliance discipline suffers. A supplier swap made under cost pressure — without proper qualification and testing — is how brands end up with an FDA observation or a recall at exactly the moment they can least afford it.

How Capsule-Based Reformulation Helps

In a tariff environment where every input cost is under pressure, the format of your product matters more than most brands realize. Capsules present a legitimate strategic opportunity, not as a compromise, but as a smarter cost structure.

Fewer Fillers and Excipients Means Less Exposure

Powder formulations require complex flavor systems — sweeteners, masking agents, acids, and gums — to make bitter or herbal ingredients palatable. Many of those flavor compounds are sourced internationally and carry their own tariff exposure.

Capsules eliminate the need for additional flavor systems entirely, making them a more cost-effective solution for brands looking to reduce the complexity of their products. Fewer ingredients in the formula means fewer line items exposed to tariff pressure and a simpler supply chain overall.

Lower Ingredient Overages Due to Better Stability

Capsule shells create a physical barrier that protects active ingredients from moisture, oxygen, and light degradation. That stability directly reduces the overage manufacturers must build into a formula to ensure label claims are met through the product's full shelf life.

In a high-cost ingredient environment, every percentage point of overage represents real money. Tighter stability means tighter formulas and lower cost per unit without compromising efficacy.

Extended Shelf Life Reduces Inventory Risk and Waste

Capsules are more stable and less prone to degradation over time compared to liquids and many powder formulations. For brands managing inventory across longer lead times — a reality in the current supply chain environment — that extended shelf life is a direct cost savings. Less waste from expired or degraded inventory. More flexibility in how much stock you can hold without risk.

Capsule Filling is Highly Efficient at Scale

The capsule manufacturing process is streamlined and highly automatable. That efficiency translates into lower labor cost per unit and faster throughput compared to more complex formulation formats that require coating, granulation, or specialized mixing equipment. Capsule filling is one of the most cost-stable formats available.

Reformulating Into Capsules Can Reduce SKU Complexity

Brands currently running multiple powder SKUs with different flavor variants often find that capsule equivalents consolidate that complexity. One capsule formula replaces three flavor variations — reducing the number of raw material inputs, simplifying procurement, and cutting the compliance and testing burden across the product line.

In a tariff environment where supply chain simplicity is a competitive advantage, fewer SKUs with cleaner formulas is a smarter operating model.

Domestic Capsule Manufacturing Sidesteps Import Exposure

Finished capsule products manufactured in the United States from domestically sourced or tariff-exempt ingredients carry significantly lower trade risk than finished goods or raw materials imported from high-tariff countries. Brands that work with US-based capsule manufacturers with strong domestic sourcing relationships are insulated from the volatility of the supply chain.

Strategic Sourcing & Rasi Labs

Tariff pressure exposes every weak point in a supplement brand's supply chain — fragmented vendors, over-complicated formulas, and manufacturing partners without the sourcing relationships to absorb volatility. 

Rasi Labs was built to eliminate those weak points. As a U.S.-based, cGMP certified contract manufacturer operating a full turnkey solution, we manage ingredient sourcing, custom formulation, in-house testing, and capsule filling under one roof. This reduces the number of supply chain handoffs where cost and compliance risk accumulate.

For brands facing margin pressure from rising dietary ingredient costs, capsule-first reformulation is one of the most practical strategies available right now. Our formulation team works directly with brand owners to evaluate existing products for reformulation opportunities. We identify where a capsule format delivers equivalent or superior efficacy at a lower cost per unit. 

What makes Rasi a genuine strategic partner in this environment is the depth of our sourcing relationships. We have vetted supplier networks built over more than a decade in the industry, with the documentation and in-house testing infrastructure to qualify alternative ingredient sources quickly — without sacrificing the compliance standards your brand depends on. 

Talk to Rasi Labs about tariff-smart capsule manufacturing strategies.